• About
  • Partnerships
  • Challenges
  • Awarded Grants
  • Grant Opportunities
  • News

Development of a Non-live Liposomal Polio Vaccine

David Moss from Lipoxen plc in the United Kingdom aims to develop a non-live polio vaccine using liposomes to entrap and deliver defined poliovirus antigens effectively to the immune system. If successful, the project will expedite the development and global deployment of a simple, economic new polio vaccine.

More information about The Poliovirus Endgame: Create ways to Accelerate, Sustain and Monitor Eradication (Round 6)

Great ideas come from everywhere.

Sign up for email updates of the latest grant opportunities and awards.

View the Grand Challenges partnership network

The Bill & Melinda Gates Foundation is part of the Grand Challenges partnership network. Visit grandchallenges.org to view the map of awarded grants across this network and grant opportunities from partners.